Brief: Index Pharmaceuticals Q2 Operating Loss At SEK 15.6 Mln
26/08/2020 07:12
Aug 26 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* Q2 OPERATING LOSS SEK 15.6 MILLION VERSUS LOSS SEK 17.7
MILLION
YEAR AGO
* WE CONTINUE WORK TO FINALIZE PHASE III DESIGN AND
ASSOCIATED
FINANCING
Source text for Eikon: ID:nWkr3vy1mq
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))